MEDICAL SCIENCES
A Brief History of Metastatic Colon Cancer
The treatment of metastatic colorectal cancer has evolved in the last several decades with the advent of new systemic therapies. This has led to improved patient outcomes and survival. While in many cases, metastatic colorectal cancer remains an incurable disease, further research and understanding of the molecular drivers of colorectal cancer will continue to advance the care of our patients. Shikha Jain, Associate Professor, Director of Communication Strategies, University of Illinois Chicago Lucia D, Notardonato, Hematology/Oncology Fellow, University of Illinois
32
A SI A N H O S P I T A L & H EA LT HCA R E M A N AGE M E N T
IS S UE - 60, 2023
C
olorectal cancer (CRC) continues to be a significant global public health challenge. In 2020, it was estimated that there were 1.9 million new CRC cases and 0.94 million CRC related deaths worldwide. With a global incidence of 10 per cent, it is the third most common cancer, and the second most common cause of global cancer-related deaths. It has been projected that the global incidence rate will continue to rise to